Former CNET editor Dong Ngo has been involved with technology since 2000, starting with testing gadgets and writing code for CNET Labs' benchmarks. He managed CNET's San Francisco Labs, reviews 3D ...
Investigators at Memorial Sloan Kettering Cancer Center (MSK) have published results from a clinical trial that found people with recurrent multiple myeloma may benefit from receiving chimeric antigen ...
CEL-SCI is all about its cancer pretreatment therapy Multikine (Leukocyte Interleukin, Injection). It is an immunotherapy consisting of a cocktail of cytokines and select small biological molecules.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback